As FDA Eyes Cough/Cold Changes, Alternative Products Aim For Mainstream
This article was originally published in The Tan Sheet
Executive Summary
Some manufacturers are anticipating changes in FDA's findings on the safety and efficacy of OTC cough/cold medicines for 2- to 11-year-old children by promoting alternative products such as nasal decongestant sprays and washing devices
You may also be interested in...
Sea Changes In Regulation And The Market: Top Stories Of 2008
When an iconic drug brand drew scrutiny on Capitol Hill for possibly violating FDA's policy against combinations of drugs and dietary supplements, OTC and supplement interests took notice
GSK Launches Breathe Right Kids, Cites Scrutiny Of Pediatric Cold Products
GlaxoSmithKline joins the list of manufacturers launching drug-free cough/cold remedies for children to meet growing demand in the wake of FDA's review of pediatric OTC drugs
Infant Cold Products Pulled; Waxman Looks For More OTC Risks
Manufacturers of OTC cough/cold medicines for children under 2 years old are voluntarily withdrawing the products from the market due to potential misuse, not from product safety concerns, the Consumer Healthcare Products Association said Oct. 11